Commentary on the article: "Maintenance of wellness in patients with obsessive-compulsive disorder who discontinue medication after exposure/response prevention augmentation A randomized clinical trial" Foa EB et al., JAMA Psychiatry. 2022;79(3):193-200 (1).

Fineberg, Naomi A; Hollander, Eric; Grant, Jon E; Chamberlain, Samuel R; Drummond, Lynne M; Pellegrini, Luca; Laws, Keith R; Wellsted, David; Reid, Jemma; Nezgovorova, Vera; Baldwin, David S

Fineberg, Naomi A; Hollander, Eric; Grant, Jon E; Chamberlain, Samuel R; Drummond, Lynne M; Pellegrini, Luca; Laws, Keith R; Wellsted, David; Reid, Jemma; Nezgovorova, Vera; Baldwin, David S.

Afiliação

Fineberg NA; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom; Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, United Kingdom; University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
Hollander E; Psychiatric Research Institute of Montefiore Einstein, Albert Einstein College of Medicine, Bronx, NY, USA.
Grant JE; Department of Psychiatry & Behavioral Neuroscience, University of Chicago, Chicago, USA.
Chamberlain SR; University of Southampton Faculty of Medicine, Southampton, United Kingdom.
Drummond LM; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom; South West London and St George's NHS Mental Health Trust, United Kingdom.
Pellegrini L; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom; Hertfordshire Partnership University NHS Foundation Trust, Welwyn Garden City, United Kingdom; Centre for Psychedelic Research, Imperial College London, London, United Kingdom. Electronic address: luca.pelleg
Laws KR; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.
Wellsted D; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.
Reid J; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom; Cornwall Partnership NHS Foundation Trust, Cornwall, United Kingdom.
Nezgovorova V; Psychiatric Research Institute of Montefiore Einstein, Albert Einstein College of Medicine, Bronx, NY, USA.
Baldwin DS; University of Southampton Faculty of Medicine, Southampton, United Kingdom.

Compr Psychiatry ; 116: 152323, 2022 07.

Article em En | MEDLINE | ID: mdl-35537294

Assuntos

Terapia Implosiva; Transtorno Obsessivo-Compulsivo; Humanos; Transtorno Obsessivo-Compulsivo/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Implosiva / Transtorno Obsessivo-Compulsivo Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Compr Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google